List of Tables
Table 1. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapies
Table 5. Key Players of Immunotherapy
Table 6. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lung Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Lung Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Lung Cancer Therapy Market Share by Region (2020-2025)
Table 10. Global Lung Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Lung Cancer Therapy Market Share by Region (2026-2031)
Table 12. Lung Cancer Therapy Market Trends
Table 13. Lung Cancer Therapy Market Drivers
Table 14. Lung Cancer Therapy Market Challenges
Table 15. Lung Cancer Therapy Market Restraints
Table 16. Global Lung Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Lung Cancer Therapy Market Share by Players (2020-2025)
Table 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2024)
Table 19. Ranking of Global Top Lung Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Lung Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Lung Cancer Therapy, Headquarters and Area Served
Table 22. Global Key Players of Lung Cancer Therapy, Product and Application
Table 23. Global Key Players of Lung Cancer Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Lung Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Lung Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Lung Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Lung Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Lung Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Lung Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Lung Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Lung Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Lung Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Lung Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. GlaxoSmithKline Company Details
Table 49. GlaxoSmithKline Business Overview
Table 50. GlaxoSmithKline Lung Cancer Therapy Product
Table 51. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 52. GlaxoSmithKline Recent Development
Table 53. Menarini Company Details
Table 54. Menarini Business Overview
Table 55. Menarini Lung Cancer Therapy Product
Table 56. Menarini Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 57. Menarini Recent Development
Table 58. Pfizer Company Details
Table 59. Pfizer Business Overview
Table 60. Pfizer Lung Cancer Therapy Product
Table 61. Pfizer Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Lung Cancer Therapy Product
Table 66. Roche Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Lung Cancer Therapy Product
Table 71. Merck Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 72. Merck Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Lung Cancer Therapy Product
Table 76. AstraZeneca Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Sanofi-Aventis Company Details
Table 79. Sanofi-Aventis Business Overview
Table 80. Sanofi-Aventis Lung Cancer Therapy Product
Table 81. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 82. Sanofi-Aventis Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Lung Cancer Therapy Product
Table 86. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott Lung Cancer Therapy Product
Table 91. Abbott Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Akebia Therapeutics Company Details
Table 94. Akebia Therapeutics Business Overview
Table 95. Akebia Therapeutics Lung Cancer Therapy Product
Table 96. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 97. Akebia Therapeutics Recent Development
Table 98. Agennix AG Company Details
Table 99. Agennix AG Business Overview
Table 100. Agennix AG Lung Cancer Therapy Product
Table 101. Agennix AG Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 102. Agennix AG Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Lung Cancer Therapy Picture
Figure 2. Global Lung Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lung Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Radiation Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Targeted Therapies Features
Figure 7. Immunotherapy Features
Figure 8. Global Lung Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Lung Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Lung Cancer Therapy Report Years Considered
Figure 14. Global Lung Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Lung Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Lung Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Lung Cancer Therapy Market Share by Players in 2024
Figure 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2024
Figure 20. North America Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 22. United States Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 26. Germany Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Lung Cancer Therapy Market Share by Region (2020-2031)
Figure 34. China Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 50. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 55. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 58. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 59. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
